Additionally, VAT can also induce obesity-related subclinical inflammatory changes, such as increased production of interleukin-6, tumour necrosis factor-α, and C-reactive protein, which can precede the pathogenesis of CKD (48, 49). The gene discussed is IL6; the disease is Obesity.